Imagen de Portada

Understanding Biomarker Discordance: MRI and PET Phenotypes Shed Light on Alzheimer’s Pathology

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Tamil Iniyan Gunasekaran, Annie J. Lee, Patrick J. Lao, Jose Gutierrez, Jennifer J. Manly, Yian Gu, Adam M. Brickman, Lawrence S. Honig, Badri N. Vardarajan, Richard Mayeux
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Alzheimer's & Dementia
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi‐ethnic Washington Heights–Hamilton Heights–Inwood Columbia Aging Project (WHICAP) cohort
por: Yian Gu, et al.
Publicado: (2024)

Polygenic scores of Core 1 Alzheimer's disease biomarkers predict early cognitive and pathological change
por: Yuexuan Xu, et al.
Publicado: (2025)

Polygenic Risk Scores for Amyloidosis as Predictors of Early changes in Alzheimer's Disease Endophenotypes
por: Yuexuan Xu, et al.
Publicado: (2025)

Contribution of cardiovascular comorbidities to Alzheimer’s Disease (AD) among older adults with low plasma AD biomarker level
por: Yian Gu, et al.
Publicado: (2024)

Association of Blood‐based Biomarkers of Alzheimer's Disease with Cognition and Educational Experiences in Midlife
por: Jennifer J. Manly, et al.
Publicado: (2025)

CSF Proteome Analysis of p ‐Tau181 and Other Alzheimer's Disease Biomarkers Identifies Autotaxin–Lysophosphatidic Acid Signaling as Potential Therapeutic Targets
por: Min N Qiao, et al.
Publicado: (2025)

Characterizing White Matter Hyperintensity (WMH) Patterns with Texture‐Based Analysis
por: Mohamad J. Alshikho, et al.
Publicado: (2024)

Association of CSF Proteome with CSF P‐tau181 levels and other biomarkers of Alzheimer's Disease
por: Min N Qiao, et al.
Publicado: (2024)

Beyond Credentials: Understanding Educational Gradients in Cognitive Function at Midlife
por: Eric Grodsky, et al.
Publicado: (2024)

Associations between parental history of Alzheimer's disease and plasma markers of immunity in a multi‐ethnic community cohort of middle‐aged adults
por: Edric D. Winford, et al.
Publicado: (2025)

Genetic variation of the Alzheimer's disease risk gene CD33 modifies microglial immunometabolism
por: Kirstin A Tamucci, et al.
Publicado: (2025)

Biological age acceleration associates with Alzheimer's disease plasma biomarker levels
por: Jaclyn M. Eissman, et al.
Publicado: (2026)

Genetic regulation of the metabolome differs by sex, Alzheimer's disease stage, and plasma biomarker status
por: Jaclyn M. Eissman, et al.
Publicado: (2025)

Does socioeconomic status modify the association between glycemic level and MRI markers of ADRD risk in middle‐aged adults?
por: A. Zarina Kraal, et al.
Publicado: (2024)

Does socioeconomic status modify the association between glycemic level and MRI markers of ADRD risk in middle‐aged adults?
por: A. Zarina Kraal, et al.
Publicado: (2024)

Socioeconomic, Biomarker, Genetic, and Cardiovascular Drivers of the Effect of Parental Alzheimer's Disease and MCI Status on Cognitive Function in Middle Age
por: Jennifer J. Manly, et al.
Publicado: (2025)

ABCA7‐dependent Neuropeptide‐Y signalling is a resilience mechanism required for synaptic integrity in Alzheimer’s disease
por: Huseyin Tayran, et al.
Publicado: (2024)

Biological age predicts dementia and Alzheimer's disease plasma biomarker levels
por: Jaclyn M. Eissman, et al.
Publicado: (2025)

Structural Variants Associated with Sporadic Alzheimer's Disease Pathologies and Segregates in Caribbean Hispanics and Non‐Hispanic White Families
por: Tamil Iniyan Gunasekaran, et al.
Publicado: (2025)

Alzheimer's and Non‐Alzheimer's FDG‐PET Patterns: Biomarker Differences and Diagnostic Performance for Amyloid and Tau Pathology
por: Kittithatch Booncharoen, et al.
Publicado: (2025)

Predicting PET‐Based Amyloid and Tau Pathology Stages With Plasma Biomarkers in Alzheimer's disease
por: Han‐Kyeol Kim, et al.
Publicado: (2024)

Clinical Phenotypes of Alzheimer’s Disease: Atrophy Patterns and their Pathological Correlates
por: Niels Reijner, et al.
Publicado: (2024)

Clinical Phenotypes of Alzheimer's Disease: Atrophy Patterns and their Pathological Correlates
por: Niels Reijner, et al.
Publicado: (2024)

Cerebrospinal fluid seed aggregation assay and Alzheimer biomarkers in a Dementia with Lewy Body cohort
por: Lawrence S. Honig, et al.
Publicado: (2025)

Racism as a Moderator of the Age‐Brain Relationship in a Multiethnic Cohort of Middle‐Aged Adults
por: Dominika Seblova, et al.
Publicado: (2025)

Editorial for “Ventricular Discordance as an MRI Phenotype Provides Prognostic Value Among Arrhythmogenic Cardiomyopathy”
por: Masaaki Takeuchi
Publicado: (2025)

Amyloid Biomarker Discordance in Patients Evaluated for Anti‐Amyloid Therapy
por: Vijay K. Ramanan, et al.
Publicado: (2024)

TPClust: Temporal Profile‐Guided Disease Subtyping Using High‐Dimensional Omics Data
por: Boyi Hu, et al.
Publicado: (2025)

FDG‐PET Outperforms MRI in Monitoring Early Neurodegenerative Changes Tied to Neurofibrillary Tangle Pathology: An Imaging‐Pathology Study
por: Orfeas Vourkas, et al.
Publicado: (2025)

Bilingualism and Immigration Status Do Not Moderate Family History of Dementia on Cognition among Middle‐Aged Latinx Adults
por: Lily Kamalyan, et al.
Publicado: (2025)

Challenges and Pitfalls in Diagnosing Twins With Discordant BWS Phenotype
por: Iacopo Bellani, et al.
Publicado: (2025)

Education and midlife cognitive functioning: Evidence from the High School and Beyond cohort
por: Chandra Muller, et al.
Publicado: (2025)

Data‐Independent Acquisition and Label‐Free Quantification for Quantitative Proteomics Analysis of Human Cerebrospinal Fluid
por: Karl A.T. Makepeace, et al.
Publicado: (2024)

Understanding #vent Channels on Discord
por: Oladeji, Kayode, et al.
Publicado: (2024)

Cognition Four Decades After High School: Does School Context Matter for Cognitive Disparities at Midlife?
por: Jennifer J. Manly, et al.
Publicado: (2024)

Dynamic Changes in Quantitative MRI‐based Biomarkers and Its Association with Pathology of Alzheimer’s Disease – A Longitudinal Study
por: Xiang Fan, et al.
Publicado: (2024)

Relationship of Mito‐Nuclear Genetics to FDG‐PET Alzheimer’s Disease Biomarkers in Aging
por: Robyn A Honea, et al.
Publicado: (2024)

Estimating the Prevalence of Alzheimer's Disease Pathology Using Plasma Biomarkers in COMPASS‐ND
por: Jennifer G Cooper, et al.
Publicado: (2025)

Effects of neflamapimod (p38α kinase inhibitor) on clinical progression in patients with dementia with Lewy bodies (DLB) without Alzheimer’s disease (AD) Co‐Pathology
por: Lawrence S. Honig, et al.
Publicado: (2025)

Empathetic Conversational Agents: Utilizing Neural and Physiological Signals for Enhanced Empathetic Interactions
por: Saffaryazdi, Nastaran, et al.
Publicado: (2025)